These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 10365121
1. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors. Pichon MF, Coquin G, Fauveau C, Rey A. Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121 [Abstract] [Full Text] [Related]
2. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse]. Łacka K, Michałek K, Majewski P. Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567 [Abstract] [Full Text] [Related]
3. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma. Bojunga J, Dragan C, Schumm-Draeger PM, Usadel KH, Kusterer K. Br J Cancer; 2001 Nov 16; 85(10):1546-50. PubMed ID: 11720443 [Abstract] [Full Text] [Related]
6. Prognostic variables and calcitonin in medullary thyroid cancer. Clark JR, Fridman TR, Odell MJ, Brierley J, Walfish PG, Freeman JL. Laryngoscope; 2005 Aug 16; 115(8):1445-50. PubMed ID: 16094121 [Abstract] [Full Text] [Related]
7. Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy. Alessandro S, Vincenzo G, Maria AG, Stefano S, Alessandro G, Salvatore M, Vincenzo T, Franco DS. Endocr Relat Cancer; 2007 Sep 16; 14(3):625-32. PubMed ID: 17914093 [Abstract] [Full Text] [Related]
8. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Béhé M, Behr TM. Biopolymers; 2002 Sep 16; 66(6):399-418. PubMed ID: 12658727 [Abstract] [Full Text] [Related]
9. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin. Mirallié E, Iacobone M, Sebag F, Henry JF. Eur J Surg Oncol; 2004 Sep 16; 30(7):790-5. PubMed ID: 15296996 [Abstract] [Full Text] [Related]
10. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C, Chen LQ, Yang GL, Li Y. Ai Zheng; 2007 Nov 16; 26(11):1221-6. PubMed ID: 17991322 [Abstract] [Full Text] [Related]
11. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer. Ogawa A, Yoshida A, Kanda T, Sugihara S, Suzuki T, Tamura J, Kobayashi I, Nakazato Y. J Med; 2000 Nov 16; 31(1-2):101-10. PubMed ID: 10998759 [Abstract] [Full Text] [Related]
12. Serum calcitonin in small cell carcinoma of the prostate. Sim SJ, Glassman AB, Ro JY, Lee JJ, Logothetis CJ, Liu FJ. Ann Clin Lab Sci; 1996 Nov 16; 26(6):487-95. PubMed ID: 8908318 [Abstract] [Full Text] [Related]
13. Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas? Franke WG, Pinkert J, Runge R, Bredow J, Wunderlich G, Koch R. Anticancer Res; 2000 Nov 16; 20(6D):5257-60. PubMed ID: 11326706 [Abstract] [Full Text] [Related]
14. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer. Nakagoe T, Sawai T, Tsuji T, Jibiki M, Ohbatake M, Nanashima A, Yamaguchi H, Kurosaki N, Yasutake T, Ayabe H, Arisawa K. J Exp Clin Cancer Res; 2001 Mar 16; 20(1):85-90. PubMed ID: 11370835 [Abstract] [Full Text] [Related]
15. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J. Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125 [Abstract] [Full Text] [Related]
16. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Ann Thorac Surg; 2004 Sep 15; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [Abstract] [Full Text] [Related]
17. Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy. Soga N, Onishi T, Arima K, Sugimura Y. Int J Urol; 2007 Mar 15; 14(3):192-6; discussion 197. PubMed ID: 17430253 [Abstract] [Full Text] [Related]
18. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM). Roobol MJ, Kranse R, de Koning HJ, Schröder FH. Urology; 2004 Feb 15; 63(2):309-13; discussion 313-5. PubMed ID: 14972478 [Abstract] [Full Text] [Related]
19. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P. Eur J Surg Oncol; 2005 Mar 15; 31(2):164-9. PubMed ID: 15698733 [Abstract] [Full Text] [Related]
20. Medullary thyroid carcinoma presenting with an initial CEA elevation. Abraham D, Delbridge L, Clifton-Bligh R, Clifton-Bligh P, Grodski S, Robinson BG, Messina M, Sidhu S. ANZ J Surg; 2010 Nov 15; 80(11):831-3. PubMed ID: 20969693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]